Results of positron emission tomography with fluorine-18-labelled fluorodeoxyglucose in staging and differential diagnosis of pancreatic cancer;ERGEBNISSE DER POSITRONEN-EMISSIONSTOMOGRAPHIE MIT FLUOR-18-MARKIERTER FLUORDESOXYGLUKOSE BEI DIFFERENTIALDIAGNOSE UND STAGING DES PANKREASKARZINOMS

Radiologe

Volumn 36, Issue 5, 1996, Pages 435-440

  Bares, R ^a,b   Dohmen, B M ^a,b   Cremerius, U ^a,b   Fass J ^b   Tausch, M ^b   Bull U ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b NONE

Author keywords

chronic pancreatitis; fluorodeoxyglucose; lymph node metastases; pancreatic cancer; positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DEOXYGLUCOSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER STAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREATITIS; POSITRON EMISSION TOMOGRAPHY; CHRONIC DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; GLUCOSE BLOOD LEVEL; METABOLISM; PANCREAS; PANCREAS RESECTION; PANCREAS TUMOR; PATHOLOGY; SCINTISCANNING;

BLOOD GLUCOSE; CHRONIC DISEASE; DEOXYGLUCOSE; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATITIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029666348     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001170050093     Document Type: Article

References (16)

1. Bares R, Klever P, Hauptmann et al (1994) F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 192: 79-86
2. Campbell JP, Wilson SR (1988) Pancreatic neoplasms: How useful is evaluation with US? Radiology 167: 341-344
3. Claussen CD (1991) Bildgebende Diagnostik des Pankreas. RöFo 155: 483-486
4. Feine U, Lietzenmayer R, Hanke JP, Wöhrle H, Müller-Schauenburg W (1995) FDG-Ganzkörper-PET bei differenzierten Schilddrüsenkarzinomen. Nucl Med 34: 127-134
5. Gehl HB, Urhahn R, Bohndorf K et al (1993) Mn-DPDP in MR imaging of pancreatic adenocarcinoma: Initial clinical experience. Radiology 186: 795-798
6. Inokuma T, Tamaki N, Torizuka T et al (1995) Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose. Radiology 195: 345-352
7. Klever P, Bares R, Pass J, Büll U, Schumpelick V (1992) PET with fluorine-18 deoxyglucose for pancreatic disease. Lancet 340: 1158-1159
8. Megibow AJ, Zhou XH, Rotterdam H et al (1995) Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability - report of the Radiology Diagnostic Oncology Group. Radiology 195: 327-332
9. Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple time uptake data. J Cereb Blood Flow Metab 3: 1-7
10. Shulkin BL, Koeppe RA, Francis IR, Deeb GM, Lloyd RV, Thomson RW (1993) Pheochromocytomas that do not accumulate metaiodobenzylguanidine: Localization with PET and administration of FDG. Radiology 186: 711-715
11. Stollfuss JC, Glatting G, Friess H, Kocher F, Beger HG, Reske SN (1995) 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: Value of quantitative image interpretation. Radiology 195: 339-344
12. Strauss LG, Conti PS (1991) Applications of PET in clinical oncology. J Nucl Med 32: 623-648
13. Tahara T, Ichiya Y, Kubawara Y, Otsuka M, Miyake Y, Gunasekera R, Masuda K (1989) High F-18 fluorodeoxyglucose uptake in abdominal abscesses: A PET study. J Comput Assist Tomogr 13: 829-831
14. Tio TL, Tytgat GNJ (1986) Endoscopic ultrasonography in staging local resectability of pancreatic and periampullary malignancy. Scand J Gastroenterol 21 [Suppl]: 135-142
15. Warshaw AL, Fernandez-Del Castillo C (1992) Pancreatic carcinoma. N Engl J Med 326: 455-465
16. Woodard HQ, Gigler RE, Freed B, Russ G (1975) Expression of tissue isotope distribution. J Nucl Med 16: 958-959